Medtronic Analyst Price Targets - Benzinga

Medtronic PLC

MDTNYSE

Trade with Public

Trade with Public

$91.27

-0.75-0.82%

Últ. Act.: Aug 27, 1:50 PM

Ganancias: Beneficios de Q1 2027 dentro de 5 días de ahora en mar sept 1st, antes de la apertura del mercado

Conferencia telefónica: Conferencia telefónica programada para dentro de 5 días a las 7:45 a. m.

Haz clic para ver el webcast

Panorámica general Noticias Previsión de beneficios EventosPrecios objetivoFinanzas Sentimiento Propiedad Dividendos Comparar Opciones Informe de acciones

Medtronic Analyst Price Targets

Wall Street analyst price targets and consensus rating for Medtronic (MDT).

Price Target Range — 9 Quarters

Analyst Consensus — 21 Analysts

15Buy

6Hold

Consensus RatingBuy# Analysts21Avg. Consensus PT$102Upside to Avg. PT+12.1%

Rating Trend — Last 9 Months

Recent Analyst Actions

View all ratings →

Date	Firm	Analyst	Action	Rating Change	Price Target
Aug 27, 2026	Needham	Mike Matson	PT Raise	Buy	$101→$114
Aug 18, 2026	BTIG	Ryan Zimmerman	Maintained	Buy	$91
Jul 28, 2026	UBS	Priya Sachdeva	Upgrade	Neutral→Buy	$85→$100
Jul 10, 2026	TD Cowen	Joshua Jennings	PT Cut	Buy	$119→$100
Jul 6, 2026	Evercore ISI Group	Vijay Kumar	PT Cut	Outperform	$106→$105
Jun 17, 2026	Needham	Mike Matson	Maintained	Buy	$101
Jun 5, 2026	Goldman Sachs	David Roman	PT Cut	Neutral	$84→$83
Jun 5, 2026	Bernstein	Lee Hambright	PT Cut	Outperform	$112→$97
Jun 4, 2026	UBS	Priya Sachdeva	PT Cut	Neutral	$90→$85
Jun 4, 2026	TD Cowen	Joshua Jennings	Maintained	Buy	$119
Jun 4, 2026	RBC Capital	Shagun Singh	Maintained	Outperform	$118
Jun 4, 2026	Wells Fargo	Larry Biegelsen	PT Cut	Overweight	$114→$102
Jun 4, 2026	Leerink Partners	Mike Kratky	PT Cut	Outperform	$117→$104
Jun 4, 2026	Baird	David Rescott	PT Cut	Neutral	$93→$85
Jun 4, 2026	BTIG	Ryan Zimmerman	Upgrade	Neutral→Buy	$90
Jun 3, 2026	Mizuho	Anthony Petrone	PT Cut	Outperform	$120→$100
Jun 3, 2026	Needham	Mike Matson	PT Cut	Buy	$120→$101
Apr 22, 2026	UBS	Priya Sachdeva	PT Cut	Neutral	$104→$90
Apr 15, 2026	Truist Securities	Richard Newitter	PT Cut	Hold	$103→$95
Apr 13, 2026	Mizuho	Anthony Petrone	PT Cut	Outperform	$125→$120

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
Needham Maintains Buy on Medtronic, Raises Price Target to $114

Needham analyst Mike Matson maintains Medtronic (NYSE:MDT) with a Buy and raises the price target from $101 to $114.

Benzinga Newsdesk

PRO
BTIG Reiterates Buy on Medtronic, Maintains $91 Price Target

BTIG analyst Ryan Zimmerman reiterates Medtronic (NYSE:MDT) with a Buy and maintains $91 price target.

Benzinga Newsdesk

Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend Yields

During market turbulence, investors turn to dividend-yielding stocks. Benzinga provides analyst ratings for high-yield stocks in health care.

Avi Kapoor

PRO
UBS Upgrades Medtronic to Buy, Raises Price Target to $100

UBS analyst Priya Sachdeva upgrades Medtronic (NYSE:MDT) from Neutral to Buy and raises the price target from $85 to $100.

Benzinga Newsdesk

Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend Yields

In times of market turbulence, dividend-yielding stocks are popular for investors. Check out analyst ratings for high-yielding stocks and recent news on Bristol-Myers Squibb, GSK, and Medtronic PLC on Benzinga's Analyst Stock Ratings page.Investors turn to dividend-yielding stocks in turbulent markets. Check out analyst ratings and news for high-yielding stocks on Benzinga's Analyst Stock Ratings page.

Avi Kapoor

Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks Delivering High-Dividend Yields

Investors turn to dividend-yielding stocks during market turbulence. Benzinga's Analyst Stock Ratings page provides latest analyst takes on top stocks, sorted by accuracy. Ratings for three high-yielding health care stocks: VTRS, MDT, GSK. VTRS to report Q2 results on Aug.6, MDT recalls certain catheter system, GSK reports positive trial results. Benzinga Pro's newsfeed provides real-time alerts.

Avi Kapoor